colistimethate sodium has been researched along with isoniazid in 1 studies
Studies (colistimethate sodium) | Trials (colistimethate sodium) | Recent Studies (post-2010) (colistimethate sodium) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
---|---|---|---|---|---|
188 | 12 | 140 | 21,815 | 960 | 4,493 |
Protein | Taxonomy | colistimethate sodium (IC50) | isoniazid (IC50) |
---|---|---|---|
Myeloperoxidase | Homo sapiens (human) | 4.85 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apostolides, Z; Buys, A; Nardell, EA; Stoltz, AC; van Breda, SV | 1 |
1 other study(ies) available for colistimethate sodium and isoniazid
Article | Year |
---|---|
The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro.
Topics: Antitubercular Agents; Cell Wall; Colistin; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Molecular Structure; Mycobacterium tuberculosis; Pulmonary Surfactants; Rifampin; Structure-Activity Relationship; Time Factors | 2015 |